CLINICAL TRIALS PROFILE FOR NAPROXEN SODIUM
✉ Email this page to a colleague
505(b)(2) Clinical Trials for Naproxen Sodium
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| OTC | NCT00751400 ↗ | Naproxen Sodium Extended-Release Actual Use Study | Completed | Pegus Research, Inc. | Phase 3 | 2008-07-01 | The purpose of this Study is to assess how subjects will use the investigational product in an uncontrolled, naturalistic environment. |
| OTC | NCT00751400 ↗ | Naproxen Sodium Extended-Release Actual Use Study | Completed | Bayer | Phase 3 | 2008-07-01 | The purpose of this Study is to assess how subjects will use the investigational product in an uncontrolled, naturalistic environment. |
| OTC | NCT01365052 ↗ | Safety Trial of Naproxen Sodium/ Diphenhydramine | Completed | Bayer | Phase 3 | 2011-05-01 | The purpose of this trial is to see how safe the combination of naproxen sodium 440 mg and diphenhydramine hydrochloride (DPH) 50 mg (the investigational product) is compared to placebo (capsules containing no drug) when taken for 10 days. |
| OTC | NCT01383486 ↗ | Self Selection Trial of Naproxen Sodium | Completed | Bayer | Phase 3 | 2011-07-01 | A pilot trial to demonstrate that consumers can appropriately select Aleve 24 Hour for their own use based on expected duration of pain greater than 12 hours. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for Naproxen Sodium
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00092729 ↗ | An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2002-06-07 | The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation). |
| NCT00114049 ↗ | Dental Pain (Following Third Molar Tooth Extraction) Study | Completed | GlaxoSmithKline | Phase 3 | 2004-12-01 | The purpose of this study is to evaluate the effectiveness of GW406381 (a COX-2 inhibitor) in treating the signs and symptoms of dental pain following third molar tooth extraction. |
| NCT00240617 ↗ | Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks | Completed | GlaxoSmithKline | Phase 3 | 2005-10-01 | The purpose of this study is to determine the consistency of response for Treximet (formerly known as Trexima) when treating four acute migraine attacks at the mild pain phase and within 1 hour of onset of head pain. |
| NCT00240630 ↗ | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks | Completed | GlaxoSmithKline | Phase 3 | 2005-10-01 | The purpose of this study is to determine the consistency of response for Treximet (sumatriptan/naproxen sodium), formerly known as Trexima, when treating four acute migraine attacks at the mild pain phase and within 1 hour of onset of head pain. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Naproxen Sodium
Condition Name
Clinical Trial Locations for Naproxen Sodium
Trials by Country
Clinical Trial Progress for Naproxen Sodium
Clinical Trial Phase
Clinical Trial Sponsors for Naproxen Sodium
Sponsor Name
